Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology
- PMID: 2349968
- PMCID: PMC1877432
Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology
Abstract
The opportunistic pathogen Pneumocystis carinii (Pc) poses a major clinical health problem in individuals with immune deficiency, including those patients with human immunodeficiency (HIV)-associated acquired immune deficiency disease (AIDS). Heretofore, in vivo investigations of the biology of Pc and pathogenesis of pneumocystosis have generally employed steroid-induced immune suppression with antibiotic prophylaxis and protein deprivation. This approach has many drawbacks, chief among them being the widespread, multiple interacting effects caused by the inducing agents. Athymic (nude) mice and rats have been used, but are less than ideal, as the immune defect primarily affects T lymphocytes. This article describes the natural history, pathobiology, and environmental effects on Pc pneumonitis in nonaxenically housed mice homozygous for the autosomal recessive mutation 'severe combined immunodeficiency' (scid), which almost totally lack both cell-mediated and antibody-mediated immune functions. The predictability, unequivocal expression, high morbidity, and well-defined genetic basis make scid/scid mutant mice the model of choice for in vivo studies of spontaneous pneumocystosis.
Similar articles
-
Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.Infect Immun. 1989 Jan;57(1):62-70. doi: 10.1128/iai.57.1.62-70.1989. Infect Immun. 1989. PMID: 2642471 Free PMC article.
-
Multiplication of human-derived Pneumocystis carinii in severe combined immunodeficient (SCID) mice.Experientia. 1992 Jan 15;48(1):63-6. doi: 10.1007/BF01923610. Experientia. 1992. PMID: 1737579
-
Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.Infect Immun. 1993 May;61(5):1641-9. doi: 10.1128/iai.61.5.1641-1649.1993. Infect Immun. 1993. PMID: 8478052 Free PMC article.
-
Animal pneumocystosis: a model for man.Vet Res. 1999 Jan-Feb;30(1):1-26. Vet Res. 1999. PMID: 10081109 Review.
-
[Pathogenesis of pneumocystis carinii pneumonia].Pneumologie. 1999 Nov;53(11):530-8. doi: 10.1055/s-1999-9046. Pneumologie. 1999. PMID: 10613069 Review. German.
Cited by
-
Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.Antimicrob Agents Chemother. 2000 Sep;44(9):2259-62. doi: 10.1128/AAC.44.9.2259-2262.2000. Antimicrob Agents Chemother. 2000. PMID: 10952565 Free PMC article.
-
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice.J Leukoc Biol. 2008 Aug;84(2):420-30. doi: 10.1189/jlb.1207816. Epub 2008 May 8. J Leukoc Biol. 2008. PMID: 18467653 Free PMC article.
-
Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.Infect Immun. 1993 Jan;61(1):97-102. doi: 10.1128/iai.61.1.97-102.1993. Infect Immun. 1993. PMID: 8418070 Free PMC article.
-
Exacerbation of Pneumocystis carinii pneumonia in immunodeficient (scid) mice by concurrent infection with a pneumovirus.Infect Immun. 1993 Apr;61(4):1586-8. doi: 10.1128/iai.61.4.1586-1588.1993. Infect Immun. 1993. PMID: 8454368 Free PMC article.
-
Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.Cold Spring Harb Perspect Med. 2015 Jul 17;5(12):a018424. doi: 10.1101/cshperspect.a018424. Cold Spring Harb Perspect Med. 2015. PMID: 26187873 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources